Stiftung für Medizininnovationen

Name

Stiftung für Medizininnovationen

Legal name

Stiftung für Medizininnovationen

Website

https://stiftung-medizininnovationen.de

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

MedTech Innovation Promotion & Startup Acceleration

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYBPAGAKAL

Health & Medical Research Grantmaking Foundations

Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

SECONDARYBPAGAKAI

Research & Science Grantmaking Foundations

Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

• Medtech startup acceleration
• Innovation promotion programs
• Medical device qualification
• Healthcare entrepreneurship support
• Biomedical research funding

Headquarters

HQ city

Tübingen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Donations and Endowments: The foundation relies on donations, sponsorships, and endowments to maintain and expand activities. Donations can be used according to foundation needs or donor preferences within the foundation's purpose. Official donation receipts are provided.
2. Prize Money from Founder: The foundation was established using prize money won by founder Prof. Zrenner through research and development of medical technology products, including the Alcon Research Award, Karl Heinz Beckurts Award, and Euretina Innovation Award.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Stiftung für Medizininnovationen is a non-profit foundation that runs qualification and acceleration programs for early-stage MedTech startups in the pre-competitive phase, anchored by the 4C Accelerator and 4C Bootcamp. It also operates the RD TREAT translational research program for hereditary retinal dystrophies in partnership with the University of Tübingen. Programs are delivered using the foundation's proprietary 4C Business Modelling methodology (Commercialization, Certification, Clinical Studies, Copyright) and through its subsidiary Medical Innovations Incubator GmbH (MII).

Product overview

Stiftung für Medizininnovationen is a non-profit foundation that operates as an innovation promotion organization rather than a traditional product company. Its core offerings consist of qualification and acceleration programs for MedTech startups, centered around the 4C Accelerator workshops and the 4C Bootcamp, which use the proprietary 4C Business Modelling methodology to address the challenges of Commercialization, Certification, Clinical Studies, and Copyright. The foundation also operates the RD TREAT Program, a significant research initiative for developing treatments for hereditary retinal dystrophies, in partnership with the University of Tübingen's Department of Ophthalmology. The foundation's subsidiary, Medical Innovations Incubator GmbH (MII), provides individual coaching and manages the company-builder platform. Additional offerings include the public lecture series "How Does the New Enter Medicine?" supported by the Hertie Foundation.

Differentiator

Problem solved

Functional benefit

Brands

• 4C Accelerator: A qualification program for early-stage MedTech startup projects focusing on Commercialization, Certification, Clinical Studies, and Copyright.
• 4C Bootcamp
• RD TREAT Program

Products and services

• 4C Accelerator A qualification program for early-stage MedTech startup projects consisting of 15 interactive workshop sessions covering Commercialization, Certification, Clinical Studies, and Copyright, followed by one year of individual coaching through Medical Innovations Incubator GmbH. Limited to 8 startup projects per round, conducted twice yearly.
• 4C Bootcamp An intensive 1.5-day workshop for early-stage MedTech startup projects from Baden-Württemberg that teaches business model development for the highly regulated healthcare industry, delivered as part of the Startup BW campaign.
• RD TREAT Program A research program focused on developing effective treatments for hereditary retinal dystrophies (Retinitis Pigmentosa), comprising three complementary therapeutic approaches: gene replacement therapy and two mutation-independent neuroprotective strategies. Delivered in partnership with the University of Tübingen Department of Ophthalmology and the Gene and RNA Therapy Center.
• How Does the New Enter Medicine? Lecture Series A public lecture series supported by the Hertie Foundation that highlights challenges for new ideas in healthcare and discusses market access rules for startups, featuring keynote speeches and discussion rounds with industry, government, and academic experts.

Quantifiable outcome

• 85 startup projects supported from idea to practical application
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Ten partnerships are on record, tiered core, major, minor and historical.

• Medical Innovations Incubator GmbH (MII)coreStrategic or Co-development Partner · 1 January 2014The foundation established its subsidiary Medical Innovations Incubator GmbH (MII) to jointly operate qualification programs. MII provides individual 4C coaching to participants who complete the foundation's workshop program, following them for one year with needs-oriented coaching.
• Life Science Accelerator Baden-WürttembergcoreStrategic or Co-development PartnerThe foundation played a significant role in developing and executing the Life Science Accelerator Baden-Württemberg, which includes two additional educational programs: the 'Medical Innovations Explorer' and the 'MedTech Start-up School'.
• Ministry of Economic Affairs, Labour and Tourism of Baden-WürttembergmajorGTM or Marketing PartnerGovernment ministry supporter that provides funding and operates the Startup BW campaign. The foundation participates in this campaign with the 4C Bootcamp program for early-stage MedTech startups in Baden-Württemberg.
• Department of Ophthalmology, University of TübingencoreStrategic or Co-development PartnerScientific cooperation agreement between University Hospital, Faculty of Medicine, and the foundation for the RD TREAT program. The department includes an eye clinic with 400+ employees and a research institute with 160+ employees, forming a highly active unit for translation from laboratory to patient.
• Gene and RNA Therapy Center, Medical Faculty of TübingencoreStrategic or Co-development PartnerThe RD TREAT program is embedded in this center, providing opportunity to transfer experience and know-how beyond ophthalmology to contribute to molecular therapy development in other disease areas.
• University of Tübingen / Eberhard Karls UniversitycoreStrategic or Co-development PartnerProf. Zrenner serves as Senior Professor and founding director of the Research Institute of Ophthalmology. The university is a key partner in research programs including the RD TREAT initiative.
• Max Planck Institute for Intelligent SystemsminorStrategic or Co-development PartnerProf. Zrenner serves as member of the Board of Trustees, representing the foundation's academic network connections.
• NMI (Natural and Medical Sciences Institute at University of Tübingen)coreStrategic or Co-development PartnerProf. Hugo Hämmerle was long-time Director and Chairman of the NMI Foundation. Prof. Zrenner is member of the Board of Trustees. The institute focuses on biologization of medical technology and technology transfer.
• Retina-Implant AGhistoricalOthersProf. Zrenner co-founded Retina-Implant AG for retinal chip development and served as Chairman of its Supervisory Board until 2021. The company has since ceased operations.
• Okuvision GmbHminorOthersProf. Zrenner serves on the Advisory Board of Okuvision GmbH, continuing involvement in ophthalmology innovation ecosystem.

Scale indicators5 records

Recent moves8 records

Expansion highlights4 records

Broad incumbents

• Max Planck Innovation GmbH: Technology transfer arm of the Max Planck Society, supporting spinouts from one of Germany's premier research networks. Comparable as a translational mechanism turning elite German academic research into MedTech/life-science ventures, anchored in a different research ecosystem.
• EXIST - Federal Ministry for Economic Affairs and Energy (BMWE): German federal startup support program (EXIST Gründerstipendium, EXIST Forschungstransfer) funding academic spinouts including in life sciences. Comparable as a public German program supporting university-derived MedTech/BioTech startup creation, though broader than MedTech.
• High-Tech Gründerfonds (HTGF): Germany's leading early-stage deep-tech and life-science venture investor, providing seed financing and incubator support. Comparable as a foundational funder of German MedTech/BioTech startups with similar accelerator-style support, though operating as a fund rather than a foundation.
• EIT Health InnoStars: European-wide health innovation network backed by the EU's EIT, running pan-European accelerator programs (e.g., InnoStars Awards, Headstart) for early-stage health startups. Comparable as a larger, EU-scale health-startup accelerator with overlapping program design and target audience.

Direct peers

• BioM Biotech Cluster Development GmbH: Munich-headquartered lead cluster management organization for biotech and MedTech in Bavaria, operating accelerator, mentoring, and funding programs for early-stage life-science and MedTech founders. Directly comparable as a regional German MedTech/life-science startup support and accelerator organization.
• Medical Valley EMN e.V. One of Germany's leading MedTech clusters based in the Erlangen-Nürnberg metropolitan region, running innovation, accelerator, and networking programs for medical technology startups. Comparable as a regionally anchored German MedTech innovation and startup support organization with government backing.
• Ascenion GmbH: Munich-based technology transfer partner for several German research institutes including Helmholtz and Leibniz life-science centers, advising and supporting spinouts in MedTech, biotech, and diagnostics. Comparable as an organization that translates German academic MedTech research into startups, with similar coaching and program elements.
• BIOPRO Baden-Württemberg GmbH: State-wide biotechnology and medical technology support agency for Baden-Württemberg that promotes, networks, and funds biotech and MedTech innovation. Directly comparable as an institution promoting medical innovation in the same home state and ecosystem.
• Life Science Factory Berlin: Berlin-based incubator and community hub specifically focused on life-science and MedTech founders, providing workspace, mentoring, and programming. Comparable as a purpose-built MedTech/life-science founder accelerator with structured qualification content.

Regional players

• Charité Entrepreneurship: Berlin-based university hospital venture unit running SPARK-BIH and other translational/accelerator programs for health and MedTech founders. Comparable as a university-anchored MedTech founder-support program with translational focus, though operating in a different German region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/stiftung-f%C3%BCr-medizininnovationen

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stiftung für Medizininnovationen